Causal Role of Immune Cells in Chronic Obstructive Pulmonary Disease: A Two-Sample Mendelian Randomization Study

References

• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):1–10. doi: 10.1056/NEJMoa032158.
   Web of Science ®Google Scholar
• Holtzman MJ, Byers DE, Alexander-Brett J, et al. The role of airway epithelial cells and innate immune cells in chronic ­respiratory disease. Nat Rev Immunol. 2014;14(10):686–698. doi: 10.1038/nri3739.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen N, Soriano J, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi: 10.1183/09031936.00133805.
   PubMed Web of Science ®Google Scholar
• Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998;53(2):129–136. doi: 10.1136/thx.53.2.129.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhou J, Wang J, et al. Progress in the mechanism and targeted drug therapy for COPD. Sig Transduct Target Ther. 2020;5(1):248. doi: 10.1038/s41392-020-00345-x.
   PubMed Web of Science ®Google Scholar
• Meng H, Long Q, Wang R, et al. Identification of the key immune-related genes in chronic obstructive pulmonary disease based on immune infiltration analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:13–24. doi: 10.2147/COPD.S333251.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xia R, Lv M, et al. Machine-learning algorithm-based prediction of diagnostic gene biomarkers related to immune infiltration in patients with chronic obstructive pulmonary disease. Front Immunol. 2022;13:740513. doi: 10.3389/fimmu.2022.740513.
   PubMed Web of Science ®Google Scholar
• Yang Y-C, Zhang M-Y, Liu J-Y, et al. Identification of ferroptosis-related hub genes and their association with immune infiltration in chronic obstructive pulmonary disease by bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:1219–1236. doi: 10.2147/COPD.S348569.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–1026. doi: 10.1016/S0140-6736(11)60988-4.
   PubMed Web of Science ®Google Scholar
• Holloway RA, Donnelly LE. Immunopathogenesis of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2013;19(2):95–102. doi: 10.1097/MCP.0b013e32835cfff5.
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Immunol Allergy Clin North Am. 2012;33(1):95–115. doi: 10.1016/j.iac.2012.10.006.
   PubMed Web of Science ®Google Scholar
• Kheradmand F, Zhang Y, Corry DB. Contribution of adaptive immunity to human COPD and experimental models of emphysema. Physiol Rev. 2023;103(2):1059–1093. doi: 10.1152/physrev.00036.2021.
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Pérez-Padilla R. Global initiative for chronic obstructive lung disease (GOLD)-2017: the alat perspective. Arch Bronconeumol. 2017;53(3):87–88. doi: 10.1016/j.arbres.2017.01.002.
   PubMed Web of Science ®Google Scholar
• McCullagh BN, Comellas AP, Ballas ZK, et al. Antibody deficiency in patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD). PLoS One. 2017;12(2):e0172437. doi: 10.1371/journal.pone.0172437.
   PubMed Web of Science ®Google Scholar
• Hoonhorst SJ, ten Hacken NH, Lo Tam Loi AT, et al. Lower corticosteroid skin blanching response is associated with severe COPD. PLoS One. 2014;9(3):e91788. doi: 10.1371/journal.pone.0091788.
   PubMed Web of Science ®Google Scholar
• Davey Smith G, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22. doi: 10.1093/ije/dyg070.
   PubMed Web of Science ®Google Scholar
• Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–R98. doi: 10.1093/hmg/ddu328.
   PubMed Web of Science ®Google Scholar
• Skrivankova VW, Richmond RC, Woolf BA, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614–1621. doi: 10.1001/jama.2021.18236.
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi: 10.1183/13993003.00164-2019.
   PubMed Web of Science ®Google Scholar
• Shrine N, Guyatt AL, Erzurumluoglu AM, et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat Genet. 2019;51(3):481–493. doi: 10.1038/s41588-018-0321-7.
   PubMed Web of Science ®Google Scholar
• Kurki MI, Karjalainen J, Palta P, et al. FinnGen: unique genetic insights from combining isolated population and national health register data. MedRxiv. 2022. doi: 10.1101/2022.03.03.22271360.
   Google Scholar
• Orrù V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036–1045. doi: 10.1038/s41588-020-0684-4.
   PubMed Web of Science ®Google Scholar
• Sidore C, Busonero F, Maschio A, et al. Genome sequencing elucidates sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet. 2015;47(11):1272–1281. doi: 10.1038/ng.3368.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhu D, Zhang D, et al. Causal role of immune cells in schizophrenia: mendelian randomization (MR) study. BMC Psychiatry. 2023;23(1):590. doi: 10.1186/s12888-023-05081-4.
   PubMed Web of Science ®Google Scholar
• Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880–1906. doi: 10.1002/sim.6835.
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi: 10.1093/ije/dyv080.
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–1998. doi: 10.1093/ije/dyx102.
   PubMed Web of Science ®Google Scholar
• Verbanck M, Chen C-Y, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi: 10.1038/s41588-018-0099-7.
   PubMed Web of Science ®Google Scholar
• Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood: do they mirror the situation in all organs? Immunol Lett. 2007;108(1):45–51. doi: 10.1016/j.imlet.2006.10.009.
   PubMed Web of Science ®Google Scholar
• Ganusov VV, De Boer RJ. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 2007;28(12):514–518. doi: 10.1016/j.it.2007.08.009.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):71–86. doi: 10.1016/j.ccm.2013.10.004.
   PubMed Web of Science ®Google Scholar
• Postma DS, Reddel HK, ten Hacken NH, et al. Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin Chest Med. 2014;35(1):143–156. doi: 10.1016/j.ccm.2013.09.010.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4(1):435–459. doi: 10.1146/annurev.pathol.4.110807.092145.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Shapiro SD, Pauwels R. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672–688. doi: 10.1183/09031936.03.00040703.
   PubMed Web of Science ®Google Scholar
• Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):524–526. doi: 10.1513/pats.200904-016DS.
   PubMedGoogle Scholar
• Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709–721. doi: 10.1016/S0140-6736(04)16900-6.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Small airways in COPD. N Engl J Med. 2004;350(26):2635–2637. doi: 10.1056/NEJMp048102.
   PubMed Web of Science ®Google Scholar
• Smyth LJ, Starkey C, Vestbo J, et al. CD4-regulatory cells in COPD patients. Chest. 2007;132(1):156–163. doi: 10.1378/chest.07-0083.
   PubMed Web of Science ®Google Scholar
• Glader P, von Wachenfeldt K, Löfdahl C-G. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med. 2006;100(6):1088–1093. doi: 10.1016/j.rmed.2005.09.025.
   PubMed Web of Science ®Google Scholar
• Sullivan AK, Simonian PL, Falta MT, et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med. 2005;172(5):590–596. doi: 10.1164/rccm.200410-1332OC.
   PubMed Web of Science ®Google Scholar
• Geerdink JX, Simons SO, Pike R, et al. Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’COPD phenotype. Respir Res. 2016;17(1):140. doi: 10.1186/s12931-016-0456-y.
   PubMedGoogle Scholar
• Kim W-D, Kim W-S, Koh Y, et al. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest. 2002;122(2):437–444. doi: 10.1378/chest.122.2.437.
   PubMed Web of Science ®Google Scholar
• Shirai T, Suda T, Inui N, et al. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD. Allergol Int. 2010;59(1):75–82. doi: 10.2332/allergolint.09-OA-0126.
   PubMedGoogle Scholar
• Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest. 2002;121(5 Suppl):160S–165S. doi: 10.1378/chest.121.5_suppl.160s.
   PubMed Web of Science ®Google Scholar
• Turato G, Zuin R, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med. 2002;166(1):105–110. doi: 10.1164/rccm.2111084.
   PubMed Web of Science ®Google Scholar
• Aubert N, Brunel S, Olive D, et al. Blockade of HVEM for prostate cancer immunotherapy in humanized mice. Cancers (Basel). 2021;13(12):3009. doi: 10.3390/cancers13123009.
   PubMed Web of Science ®Google Scholar
• Deng Z, Zheng Y, Cai P, et al. The role of B and T lymphocyte attenuator in respiratory system diseases. Front Immunol. 2021;12:635623. doi: 10.3389/fimmu.2021.635623.
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock H. Definition of human blood monocytes. J Leukoc Biol. 2000;67(5):603–606. doi: 10.1002/jlb.67.5.603.
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14(6):392–404. doi: 10.1038/nri3671.
   PubMed Web of Science ®Google Scholar
• Han J, Wang B, Han N, et al. CD14highCD16+ rather than CD14lowCD16+ monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr. 2009;52(5):553–559. doi: 10.1097/qai.0b013e3181c1d4fe.
   PubMed Web of Science ®Google Scholar
• Valcour VG, Shiramizu BT, Shikuma CM. HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol. 2010;87(4):621–626. doi: 10.1189/jlb.0809571.
   PubMed Web of Science ®Google Scholar
• Heine G, Ulrich C, Seibert E, et al. CD14++ CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 2008;73(5):622–629. doi: 10.1038/sj.ki.5002744.
   PubMed Web of Science ®Google Scholar
• Kapellos TS, Bonaguro L, Gemünd I, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10:2035. doi: 10.3389/fimmu.2019.02035.
   PubMed Web of Science ®Google Scholar
• Serbina NV, Jia T, Hohl TM, et al. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26(1):421–452. doi: 10.1146/annurev.immunol.26.021607.090326.
   PubMedGoogle Scholar
• Tolouei Semnani R, Moore V, Bennuru S, et al. Human monocyte subsets at homeostasis and their perturbation in numbers and function in filarial infection. Infect Immun. 2014;82(11):4438–4446. doi: 10.1128/IAI.01973-14.
   PubMed Web of Science ®Google Scholar
• Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349–362. doi: 10.1038/nri.2017.28.
   PubMed Web of Science ®Google Scholar
• Stolk J, Aggarwal N, Hochnadel I, et al. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin. Respir Med. 2019;148:60–62. doi: 10.1016/j.rmed.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Yang J, Qiao M, Li Y, et al. Expansion of a population of large monocytes (atypical monocytes) in peripheral blood of patients with acute exacerbations of chronic obstructive pulmonary diseases. Mediators Inflamm. 2018;2018:9031452–9031413. doi: 10.1155/2018/9031452.
   PubMed Web of Science ®Google Scholar
• Bühling F, Ittenson A, Kaiser D, et al. MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia. Immunol Lett. 2000;71(3):185–190. doi: 10.1016/s0165-2478(00)00164-4.
   PubMed Web of Science ®Google Scholar
• Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006;32(8):1175–1183. doi: 10.1007/s00134-006-0204-8.
   PubMed Web of Science ®Google Scholar
• Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: a major regulator of leukocyte adhesion, migration and signaling. Front Immunol. 2019;10:1068. doi: 10.3389/fimmu.2019.01068.
   PubMed Web of Science ®Google Scholar
• Tak T, Wijten P, Heeres M, et al. Human CD62Ldim neutrophils identified as a separate subset by proteome profiling and in vivo pulse-chase labeling. Blood. 2017;129(26):3476–3485. doi: 10.1182/blood-2016-07-727669.
   PubMed Web of Science ®Google Scholar
• Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med. 1995;181(6):2259–2264. doi: 10.1084/jem.181.6.2259.
   PubMed Web of Science ®Google Scholar
• Noguera A, Sala E, Pons AR, et al. Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. Chest. 2004;125(5):1837–1842. doi: 10.1378/chest.125.5.1837.
   PubMed Web of Science ®Google Scholar
• Romano SJ. Selectin antagonists: therapeutic potential in asthma and COPD. Treat Respir Med. 2005;4(2):85–94. doi: 10.2165/00151829-200504020-00002.
   PubMedGoogle Scholar
• Arbonés ML, Ord DC, Ley K, et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity. 1994;1(4):247–260. doi: 10.1016/1074-7613(94)90076-0.
   PubMed Web of Science ®Google Scholar
• Mallia P, Contoli M, Gray KK, et al. Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. Respir Res. 2013;14(1):72. doi: 10.1186/1465-9921-14-72.
   PubMedGoogle Scholar
• Lokwani R, Wark PA, Baines KJ, et al. Blood neutrophils in COPD but not asthma exhibit a primed phenotype with downregulated CD62L expression. Int J Chron Obstruct Pulmon Dis. 2019;14:2517–2525. doi: 10.2147/COPD.S222486.
   PubMed Web of Science ®Google Scholar